MedTrace Logo

Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors

NCT04675346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2022-11-22

No results posted yet for this study

Summary

This is a prospective, multi-centred cohort study whereby the EUNASS Study questionnaire will be administered electronically to identify needs of melanoma survivors, the extent to which these needs are being met, and identify areas which have the greatest need for development. It will also evaluate behaviour in relation to sun protection and skin self-examination (SSE). It will be a self-completed questionnaire.

Qualitative work using semi-structured interviews will explore the needs of melanoma survivors in greater depth, will present examples of potential interventions to improve SSE and explore factors that determine the likelihood of engaging in an intervention which can address unmet needs, such as improving SSE. Taken together, the data will provide the evidence base to inform the development of an intervention to improve SSE, which can subsequently be tested in secondary care services.

Conditions

  • Melanoma, Stage I
  • Melanoma Stage III
  • Melanoma, Stage II

Interventions

OTHER

Questionnaire

Questionnaire

Sponsors & Collaborators

  • Barts & The London NHS Trust

    collaborator OTHER

  • Ninewells Hospital

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • Oxford University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Rubeta Matin · Oxford University Hospitals NHS Trust

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2022-03-31
Completion
2022-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04675346 on ClinicalTrials.gov